Creatine Supplementation During GLP-1a Therapy
ConditionSarcopenia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Saskatchewan
About this trial
GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.
Eligibility criteria
Qualifiers
Starting GLP-1 agonist therapy
18 years of age or older
Disqualifiers
Positive answers to a screening questionnaire for physical activity safety (the Get Active Questionnaire)
Trial design
Treatments tested in this trial
- Dietary supplementation during a 12 week resistance-training program (creatine)
- Dietary supplementation during a 12 week resistance-training program (placebo)
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov